about
The Molecular and Cellular Effect of Homocysteine Metabolism Imbalance on Human HealthAnticipatory role of high density lipoprotein and endothelial dysfunction: an overviewMildly acidic conditions eliminate deamidation artifact during proteolysis: digestion with endoprotease Glu-C at pH 4.5.Protective Action of Anandamide and Its COX-2 Metabolite against l-Homocysteine-Induced NLRP3 Inflammasome Activation and Injury in Podocytes.Reduced paraoxonase 1 activity as a marker for severe coronary artery disease.Contribution of endogenously produced reactive oxygen species to the activation of podocyte NLRP3 inflammasomes in hyperhomocysteinemia.Paraoxonase 1 in neurological disorders.Homocysteine, Paraoxonase-1 and Vascular Endothelial Dysfunction: Omnibus viis Romam Pervenitur.Atherogenesis: hyperhomocysteinemia interactions with LDL, macrophage function, paraoxonase 1, and exercise.Methionine-induced hyperhomocysteinemia impairs the antioxidant ability of high-density lipoproteins without reducing in vivo macrophage-specific reverse cholesterol transport.Homocysteine pre-treatment increases redox capacity in both endothelial and tumor cells.New chemiluminescent substrates of paraoxonase 1 with improved specificity: synthesis and properties.NLRP3 inflammasome as a novel target for docosahexaenoic acid metabolites to abrogate glomerular injury.Design of two and three input molecular logic gates using non-Watson-Crick base pairing-based molecular beacons.The genetic association between PON1 polymorphisms and osteonecrosis of femoral head: A case-control study.Paraoxonase (PON)-1: a brief overview on genetics, structure, polymorphisms and clinical relevance.Homocysteine as a Biomarker in Vascular Disease
P2860
Q28076483-91180C0F-F1D2-4233-B262-4B01B6D2EA63Q34950045-E764171C-4C30-43D7-9BED-BA5402CD90C9Q35889468-5759D7A3-F4AA-44F4-B2B8-D893631AECC4Q37062591-A046881A-02AF-4087-9861-ECFCFBCF33D0Q37176653-1BBBD594-3396-4DE9-A2BA-A04ACC6C4798Q37622159-9ACB51B3-CFB3-47CF-A648-BDCF56DD2644Q38162323-988C6AD2-6239-415A-A4EF-C893038AA915Q38266911-3CE47A6A-E710-4F3A-96E0-A7F9622B8830Q38724228-559CA318-D037-46F2-A02A-277B151DC211Q39141274-32E53205-481D-4A63-810D-F6FD28266393Q39751865-6A94305F-653C-4B97-8B06-C84C6EC2EE50Q41158626-092F15B9-4994-4304-A06E-17ABBA6A68E5Q45057004-B25C8F95-E61D-49EA-81B2-3B4A39D91829Q45841468-02093BBD-3ACE-478B-802F-F4B502F6D130Q47108138-3356B4E2-0880-4D11-A4EA-06AE269C1D83Q55432293-D7047A52-6A56-448C-A1F9-BEEC4FCB6339Q59085502-65A21809-A9EA-4106-8157-17133FB1D6FC
P2860
description
2012 nî lūn-bûn
@nan
2012 թուականի Մայիսին հրատարակուած գիտական յօդուած
@hyw
2012 թվականի մայիսին հրատարակված գիտական հոդված
@hy
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
name
Paraoxonase 1 and homocysteine metabolism.
@ast
Paraoxonase 1 and homocysteine metabolism.
@en
type
label
Paraoxonase 1 and homocysteine metabolism.
@ast
Paraoxonase 1 and homocysteine metabolism.
@en
prefLabel
Paraoxonase 1 and homocysteine metabolism.
@ast
Paraoxonase 1 and homocysteine metabolism.
@en
P2860
P1433
P1476
Paraoxonase 1 and homocysteine metabolism
@en
P2093
Joanna Perła-Kaján
P2860
P2888
P304
P356
10.1007/S00726-012-1321-Z
P577
2012-05-29T00:00:00Z